R
Ralph B. D'Agostino
Researcher at Wake Forest University
Publications - 1336
Citations - 250792
Ralph B. D'Agostino is an academic researcher from Wake Forest University. The author has contributed to research in topics: Framingham Heart Study & Framingham Risk Score. The author has an hindex of 226, co-authored 1287 publications receiving 229636 citations. Previous affiliations of Ralph B. D'Agostino include VA Boston Healthcare System & University of Illinois at Urbana–Champaign.
Papers
More filters
Journal ArticleDOI
Cardiovascular disease risk factors in youth with type 1 and type 2 diabetes: implications of a factor analysis of clustering.
Elizabeth J. Mayer-Davis,Bo Ma,Andrew B. Lawson,Ralph B. D'Agostino,Angela D. Liese,Ronny A. Bell,Dana Dabelea,Lawrence M. Dolan,David J. Pettitt,Beatriz L. Rodriguez,Desmond E. Williams +10 more
TL;DR: There is little evidence that a single factor underlies the CVD risk factor pattern in youths with diabetes, and the concept of the metabolic syndrome provides a useful description of clinical characteristics but does not efficiently capture a single target for etiologic research among youths with Diabetes.
Journal ArticleDOI
Ki-ras mutations are an early event and correlate with tumor stage in transplacentally-induced murine lung tumors
Sandra Leone-Kabler,Lisa L. Wessner,Michael F. McEntee,Ralph B. D'Agostino,Mark Steven Miller +4 more
TL;DR: Data suggest that mutational activation of the Ki-ras gene locus is an early event in transplacental lung tumorigenesis, and that the type of mutations produced by exposure to chemical carcinogens can influence the carcinogenic potential of the tumor.
Journal ArticleDOI
Contemporary trends in dyslipidemia in the Framingham Heart Study.
Erik Ingelsson,Joseph M. Massaro,Patrice Sutherland,Paul F. Jacques,Daniel Levy,Ralph B. D'Agostino,Ramachandran S. Vasan,Sander J. Robins +7 more
TL;DR: During a 10-year period of recent examinations in the Framingham Heart Study there was a decrease in dyslipidemia with an increase in HDL-C levels and a decreases in levels of TG despite an overall increase in BMI.
Journal ArticleDOI
Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study
Amanda L. Schwer,Ari Ballonoff,Robert McCammon,Kyle E. Rusthoven,Ralph B. D'Agostino,Tracey E. Schefter +5 more
TL;DR: The results support the use of NeoRT for patients with esophageal cancer, and on multivariate analysis, NeoRT, age <65 years, adenocarcinoma histologic type, female gender, pN0 status, >10 nodes dissected, and Stage T2 disease were all independently correlated with increased OS.
Journal ArticleDOI
Alcohol consumption and risk of lung cancer: the Framingham Study.
Luc Djoussé,Joanne F. Dorgan,Yuqing Zhang,Arthur Schatzkin,Maggie Y. Hood,Ralph B. D'Agostino,Donna L. Copenhafer,Bernard E. Kreger,R. Curtis Ellison +8 more
TL;DR: Alcohol consumption among subjects in the Framingham Study, most of whom were light to moderate drinkers, was not statistically significantly associated with the risk of lung cancer.